AR062715A1 - Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoico - Google Patents
Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoicoInfo
- Publication number
- AR062715A1 AR062715A1 ARP070103975A ARP070103975A AR062715A1 AR 062715 A1 AR062715 A1 AR 062715A1 AR P070103975 A ARP070103975 A AR P070103975A AR P070103975 A ARP070103975 A AR P070103975A AR 062715 A1 AR062715 A1 AR 062715A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- formula
- unsubstituted
- compound
- benzoico
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Reivindicacion 5: Un proceso para preparar un compuesto de la formula (1) o una sal farmacéuticamente aceptable de éste, caracterizado porque: R1 es un alquilo sustituido o no sustituido, un cicloalquilo sustituido o no sustituido, un heterocicloalquilo sustituido o no sustituido, un arilo sustituido o no sustituido, un heteroarilo sustituido o no sustituido, -(CH2CH2O)nR6 o cualquier grupo biohidrolizable; X es en cada caso independientemente F, CI, Br o I; y m es un numero entero de 1 a 5, que comprende realizar las siguientes etapas en el mismo solvente: (1) hacer reaccionar el éster de ácido cianobenzoico de (formula 2) con hidroxilamina, para producir el compuesto de formula (3), seguido por (2) acilacion con un cloruro de halobenzoilo, para producir: el compuesto de formula (4) seguido por (3) condensacion.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84359506P | 2006-09-08 | 2006-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR062715A1 true AR062715A1 (es) | 2008-11-26 |
Family
ID=38935880
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070103975A AR062715A1 (es) | 2006-09-08 | 2007-09-07 | Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoico |
ARP170100223A AR107474A2 (es) | 2006-09-08 | 2017-01-27 | Proceso para la preparación de un ácido de 1,2,4-oxadiazol benzoico |
ARP200101362A AR118922A2 (es) | 2006-09-08 | 2020-05-12 | Procesos para la preparación de ácidos de 1,2,4-oxadiazol benzoico |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP170100223A AR107474A2 (es) | 2006-09-08 | 2017-01-27 | Proceso para la preparación de un ácido de 1,2,4-oxadiazol benzoico |
ARP200101362A AR118922A2 (es) | 2006-09-08 | 2020-05-12 | Procesos para la preparación de ácidos de 1,2,4-oxadiazol benzoico |
Country Status (25)
Country | Link |
---|---|
US (2) | US7678922B2 (es) |
EP (1) | EP2059513B1 (es) |
JP (2) | JP5955494B2 (es) |
KR (1) | KR101466368B1 (es) |
CN (1) | CN101535284B (es) |
AR (3) | AR062715A1 (es) |
AU (1) | AU2007292915B2 (es) |
BR (1) | BRPI0716996B8 (es) |
CA (2) | CA2842625C (es) |
CL (1) | CL2007002606A1 (es) |
DK (1) | DK2059513T3 (es) |
ES (1) | ES2404348T3 (es) |
HK (1) | HK1134094A1 (es) |
IL (1) | IL197445A (es) |
MX (1) | MX2009002439A (es) |
MY (1) | MY148598A (es) |
NZ (2) | NZ598012A (es) |
PE (2) | PE20080771A1 (es) |
PL (1) | PL2059513T3 (es) |
PT (1) | PT2059513E (es) |
RU (1) | RU2495030C2 (es) |
TW (1) | TWI482761B (es) |
UA (1) | UA99265C2 (es) |
WO (1) | WO2008030570A1 (es) |
ZA (1) | ZA200901782B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA84420C2 (ru) | 2003-04-11 | 2008-10-27 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | СОЕДИНЕНИЯ 1,2,4-ОКСАДИАЗОЛБЕНЗОЙНОЙ КИСЛОТЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ (ВАРИАНТЫ) И ПРИМЕНЕНИЕ СОЕДИНЕНИЙ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, СВЯЗАННОГО С ПРЕЖДЕВРЕМЕННОЙ ТЕРМИНАЦИЕЙ ТРАНСЛЯЦИИ ИЛИ НОНСЕНС-ОБУСЛОВЛЕННЫМ УМЕНЬШЕНИЕМ мРНК |
JP5800451B2 (ja) | 2005-04-08 | 2015-10-28 | ピーティーシー セラピューティクス,インコーポレーテッド | ナンセンス突然変異抑制治療用の、経口的に活性な1,2,4−オキサジアゾール組成物 |
JP5367563B2 (ja) * | 2006-03-30 | 2013-12-11 | ピーティーシー セラピューティクス,インコーポレーテッド | ナンセンス突然変異を有するdnaからの機能的タンパク質の産生のための方法及びそれと関連した障害の治療 |
CA2842625C (en) * | 2006-09-08 | 2016-07-12 | Ptc Therapeutics, Inc. | Processes for the preparation of 1,2,4-oxadiazole benzoic acids |
EP2068871B1 (en) | 2006-09-25 | 2013-12-25 | PTC Therapeutics, Inc. | Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression |
PL2559689T3 (pl) | 2006-09-25 | 2018-04-30 | Ptc Therapeutics, Inc. | Sposób wytwarzania postaci krystalicznych kwasu 3-[5-(2-fluorofenylo)[1,2,4]oksadiazol-3-ilo]benzoesowego |
PL2073805T3 (pl) | 2006-10-12 | 2015-08-31 | Ptc Therapeutics Inc | Sposoby dawkowania 1,2,3-oksadiazolu aktywnego po podaniu doustnym w terapii supresyjnej mutacji nonsensownej |
CN101714009A (zh) * | 2009-05-14 | 2010-05-26 | 翁印嵩 | 集成通用电话功能的计算机 |
EP2668951B9 (en) | 2011-01-25 | 2017-03-15 | Viviabiotech, S.L. | 1,2,4-oxadiazole derivatives as drugs modulating the glp-1 peptide receptor |
MX352351B (es) | 2012-07-02 | 2017-11-21 | Monsanto Technology Llc | Procesos para la preparacion de 1,2,4-oxadiazoles 3,5-disustituidos. |
CA3174516A1 (en) | 2014-03-06 | 2015-09-11 | Ptc Therapeutics, Inc. | Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid |
CN105461650B (zh) * | 2014-09-12 | 2018-04-13 | 杭州普晒医药科技有限公司 | 一种噁二唑化合物的溶剂化物及其制备方法 |
CN106316885B (zh) * | 2015-07-03 | 2019-02-12 | 普济生物科技(台州)有限公司 | 一种3-[5-(2-氟苯基)-1,2,4-噁二唑-3-基]苯甲酸的制备方法 |
WO2017075312A1 (en) | 2015-10-30 | 2017-05-04 | Ptc Therapeutics, Inc. | Methods for treating epilepsy |
TW201808922A (zh) | 2016-06-20 | 2018-03-16 | 台灣神隆股份有限公司 | 製備阿塔魯仁及其中間體的方法 |
US20220071965A1 (en) | 2018-12-20 | 2022-03-10 | Pfizer Inc. | Pharmaceutical Compositions and Methods Comprising A Combination of a Benzoxazole Transthyretin Stabilizer and an Additional Therapeutic Agent |
WO2022112919A1 (en) | 2020-11-25 | 2022-06-02 | Pfizer Inc. | (aza)benzothiazolyl substituted pyrazole compounds |
CN113045510B (zh) * | 2021-03-31 | 2022-05-27 | 北京大学生命科学华东产业研究院 | 一种阿塔鲁伦的制备方法 |
CN114920667B (zh) * | 2022-06-30 | 2024-06-21 | 湖南大学 | 一种阿塔鲁伦酯的电化学制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2801509A1 (de) * | 1978-01-12 | 1979-07-19 | Schering Ag | 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel |
DE3905242A1 (de) * | 1989-02-21 | 1990-08-23 | Basf Ag | Verfahren zur herstellung von phenyloxdiazolylanilinen |
NZ234760A (en) * | 1989-08-18 | 1991-09-25 | Sterling Drug Inc | Antiviral oxazole compounds and compositions |
DE4425794A1 (de) * | 1994-07-21 | 1996-01-25 | Basf Ag | Nitrofarbstoffe |
US6660753B2 (en) * | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
CN1638776A (zh) * | 2001-06-08 | 2005-07-13 | 西托维亚公司 | 取代的3-芳基-5-芳基-[1,2,4]-噁二唑和类似物 |
MY151199A (en) * | 2001-11-02 | 2014-04-30 | Rigel Pharmaceuticals Inc | Substituted diphenyl heterocycles useful for treating hcv infection |
TW200812986A (en) * | 2002-08-09 | 2008-03-16 | Nps Pharma Inc | New compounds |
GB0303503D0 (en) | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
UA84420C2 (ru) * | 2003-04-11 | 2008-10-27 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | СОЕДИНЕНИЯ 1,2,4-ОКСАДИАЗОЛБЕНЗОЙНОЙ КИСЛОТЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ (ВАРИАНТЫ) И ПРИМЕНЕНИЕ СОЕДИНЕНИЙ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, СВЯЗАННОГО С ПРЕЖДЕВРЕМЕННОЙ ТЕРМИНАЦИЕЙ ТРАНСЛЯЦИИ ИЛИ НОНСЕНС-ОБУСЛОВЛЕННЫМ УМЕНЬШЕНИЕМ мРНК |
US20050075375A1 (en) * | 2003-05-14 | 2005-04-07 | Anadys Pharmaceuticals, Inc. | Heterocyclic compounds for treating hepatitis C virus |
JP5800451B2 (ja) | 2005-04-08 | 2015-10-28 | ピーティーシー セラピューティクス,インコーポレーテッド | ナンセンス突然変異抑制治療用の、経口的に活性な1,2,4−オキサジアゾール組成物 |
CA2842625C (en) * | 2006-09-08 | 2016-07-12 | Ptc Therapeutics, Inc. | Processes for the preparation of 1,2,4-oxadiazole benzoic acids |
-
2007
- 2007-09-06 CA CA2842625A patent/CA2842625C/en active Active
- 2007-09-06 UA UAA200903350A patent/UA99265C2/ru unknown
- 2007-09-06 KR KR1020097007202A patent/KR101466368B1/ko active IP Right Grant
- 2007-09-06 RU RU2009113019/04A patent/RU2495030C2/ru active
- 2007-09-06 JP JP2009527430A patent/JP5955494B2/ja active Active
- 2007-09-06 AU AU2007292915A patent/AU2007292915B2/en active Active
- 2007-09-06 PL PL07837899T patent/PL2059513T3/pl unknown
- 2007-09-06 DK DK07837899.9T patent/DK2059513T3/da active
- 2007-09-06 ES ES07837899T patent/ES2404348T3/es active Active
- 2007-09-06 US US11/899,813 patent/US7678922B2/en active Active - Reinstated
- 2007-09-06 NZ NZ598012A patent/NZ598012A/xx unknown
- 2007-09-06 MX MX2009002439A patent/MX2009002439A/es active IP Right Grant
- 2007-09-06 EP EP07837899A patent/EP2059513B1/en active Active
- 2007-09-06 MY MYPI20090941A patent/MY148598A/en unknown
- 2007-09-06 CA CA2662749A patent/CA2662749C/en active Active
- 2007-09-06 PT PT78378999T patent/PT2059513E/pt unknown
- 2007-09-06 BR BRPI0716996A patent/BRPI0716996B8/pt active IP Right Grant
- 2007-09-06 WO PCT/US2007/019561 patent/WO2008030570A1/en active Application Filing
- 2007-09-06 ZA ZA200901782A patent/ZA200901782B/xx unknown
- 2007-09-06 NZ NZ575511A patent/NZ575511A/en unknown
- 2007-09-06 CN CN200780041169.XA patent/CN101535284B/zh active Active
- 2007-09-07 PE PE2007001203A patent/PE20080771A1/es active IP Right Grant
- 2007-09-07 AR ARP070103975A patent/AR062715A1/es not_active Application Discontinuation
- 2007-09-07 CL CL200702606A patent/CL2007002606A1/es unknown
- 2007-09-07 PE PE2011001405A patent/PE20120669A1/es active IP Right Grant
- 2007-09-07 TW TW096133607A patent/TWI482761B/zh active
-
2009
- 2009-03-05 IL IL197445A patent/IL197445A/en active IP Right Grant
- 2009-11-13 US US12/617,757 patent/US8367841B2/en active Active
-
2010
- 2010-03-01 HK HK10102172.4A patent/HK1134094A1/xx unknown
-
2014
- 2014-05-20 JP JP2014103966A patent/JP2014193896A/ja active Pending
-
2017
- 2017-01-27 AR ARP170100223A patent/AR107474A2/es not_active Application Discontinuation
-
2020
- 2020-05-12 AR ARP200101362A patent/AR118922A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR062715A1 (es) | Procesos para la preparacion de acidos de 1,2,4- oxadiazol benzoico | |
BRPI0415855A (pt) | processo para preparação de ésteres de ácido 2-dihalogenacil-3-amino-acrìlico e ésteres de ácido 3-dihalogeno-metil-pirazol-4-carboxìlico | |
BR112014014148A2 (pt) | misturas de ácidos difosfínicos e dialquilfosfínicos, processo para produção das mesmas e uso das mesmas | |
NI201200051A (es) | Nuevos maitansinoides y el uso de dichos maitansonoides para preparar conjugados con un anticuerpo. | |
DE602004024545D1 (de) | Indungen | |
CR9221A (es) | Procesos para preparar eteres aromaticos | |
AR057909A1 (es) | Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico. | |
JP2009517412A5 (es) | ||
BR112012024403A2 (pt) | processo de preparo de derivados de amino-benzofurano | |
EA200600760A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их | |
JP2007045816A5 (ja) | カルバゾール誘導体、発光素子用材料として用いられるアントラセン誘導体の作製方法 | |
BR112012005126A2 (pt) | Cristalização de 4'-epidaunorubicina x hcl | |
PE20070526A1 (es) | Metodos para preparar derivados de acido glutamico | |
DE60014088D1 (de) | Verfahren zur herstellung von (nitroxymethyl)phenylestern von salicylsäurederivaten | |
AR059375A1 (es) | Procedimiento para produccion de 5-alcoxi-4-hidroximetilpirazol y compuestos | |
DK1999159T3 (da) | Fremgangsmåde til isolering og stabilisering af lavmolekylvægt-aminoglycanforbindelser fra spildæggeskaller | |
DE60330152D1 (de) | Verfahren zur herstellung von nitrooxyderivaten von naproxen | |
AR049477A1 (es) | Proceso para preparar derivados de n-aril piperazina. productos relacionados y composiciones farmaceuticas. | |
DE602006014054D1 (de) | Verfahren zur Herstellung von Aminoadamantanen | |
CN1931855A (zh) | 具有光学活性的2-羟甲基-3-取代苯基丙酸化合物及其拆分方法 | |
FR2964978B1 (fr) | Nouveaux substrats fluorescents, procede d'obtention de ces produits et leur application | |
ATE539071T1 (de) | Verfahren zur herstellung von s-(-)-6-hydroxy-2,5,7,8-tetramethylchroman-2-ca bonsäure | |
AR074151A1 (es) | Un derivado de benzoilbencenoacetamida, proceso de preparacion del mismo, forma polimorfica b de dicho compuesto, proceso de obtencion de dicha forma polimorfica b y su uso | |
BR112012012908A2 (pt) | processo de preparo de um derivado de combretastatina | |
BR112019009804A2 (pt) | 4-((6-bromopiridin-3-il)óxi)benzonitri¬la e processos de preparação |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |